News Focus
News Focus
Followers 5
Posts 711
Boards Moderated 0
Alias Born 04/04/2003

Re: Zeev Hed post# 442133

Tuesday, 12/06/2005 8:57:49 PM

Tuesday, December 06, 2005 8:57:49 PM

Post# of 704047
Well I guess it was today after all, and it turns out to be 9 million instead of 7 million. I dont know if that's good or bad (more dilution, but apparently more interest in owning the stock).


DJ ViroPharma 9M-Shr Offering Priced at $16 Each ?

06 Dec 20:18

NEW YORK (Dow Jones)--ViroPharma Inc.'s (VPHM) secondary offering of 9
million shares was priced at $16 each.

The company previously expected to offer 7 million shares.

Last month, the company said it would grant the underwriters the option to
purchase up to an addtional 1.05 million shares.

Goldman Sachs & Co. was sole book-running manager for the offering. Piper
Jaffray & Co. was the joint lead manager and SG Cowen & Co. LLC and Lazard
Capital Markets LLC were co-managers of the offering.

ViroPharma intends to use net proceeds from the offering for working capital
and general corporate purposes. The company also said it may use a portion of
the net proceeds to repay or prepay all or a portion of its 6% subordinated
convertible notes due March 2007 and for business development purposes.

-Freddy Sebastian; Dow Jones Newswires; 201-938-5400;
AskNewswires@dowjones.com

Order free Annual Report for ViroPharma Incorporated
Visit http://djnewswires.ar.wilink.com/?link=VPHM or call 1-888-301-0513
(END) Dow Jones Newswires
12-06-05 2018ET
Copyright (c) 2005 Dow Jones & Company, Inc.


Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today